Danielle Beaulieu BSc, PhD

Danielle obtained her PhD in biochemistry from Laval University Canada. After a 13-year career in microbiology drug discovery, she moved into regulatory operations where she managed several drugs at different stages of development in the US and EU. In 2014 Bristol-Myers Squibb began working toward replacing their older RIM solution with a new authoritative source for RIM, and selected the Veeva Vault RIM suite to accomplish that goal. Danielle has been the business lead for that effort from process definition/simplification to configuration, change management, and roll out.